Page 6 - Pascal Touchon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascal touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascal Touchon Today - Breaking & Trending Today

Experimental cell therapy ATA188 fails to show benefits in MS trial

Experimental cell therapy ATA188 fails to show benefits in MS trial
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Pascal Touchon , Expanded Disability Status Scale ,

Atara Biotherapeutics To Participate at the Stifel Healthcare Conference

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and. ....

United States , Pascal Touchon , Atara Biotherapeutics Inc , Chief Executive Officer , Stifel Healthcare Conference , New York ,

Atara Biotherapeutics To Participate at the Stifel Healthcare Conference

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal. ....

United States , Pascal Touchon , Product Service , Atara Biotherapeutics Inc , Stifel Healthcare , Chief Executive Officer , Stifel Healthcare Conference , New York ,

Why Atara Biotherapeutics (ATRA) Shares Are Plummeting Today - Atara Biotherapeutics (NASDAQ:ATRA)

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares are trading lower after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint of confirmed disability improvement (CDI) by expanded disabi ....

Pascal Touchon , Pierre Fabre , Atara Biotherapeutics Inc , Chief Executive Officer , Biologics License Application ,

ATARA Biotherapeutics (ATRA) Reports Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188

ATARA Biotherapeutics (ATRA) Reports Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pascal Touchon , Pierre Fabre , Atara Biotherapeutics Inc , Chief Executive Officer , Biologics License Application ,